Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Masaki Hiraguri"'
Autor:
Takahiro Sugiyama, Shunsuke Furuta, Masaki Hiraguri, Kei Ikeda, Yosuke Inaba, Shin-ichiro Kagami, Yasuhiko Kita, Kei Kobayashi, Yoshihisa Kobayashi, Kazuhiro Kurasawa, Daiki Nakagomi, Yasushi Nawata, Yohei Kawasaki, Yuki Shiko, Takao Sugiyama, Hiroshi Nakajima
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-10 (2022)
Abstract Background Adult-onset Still’s disease (AOSD) is a rare systemic autoinflammatory disease which encompasses patients with heterogenous presentation and a wide range of clinical courses. In this study, we aimed to identify potential subgrou
Externí odkaz:
https://doaj.org/article/8702c9c7492344b18c0bfa86e1863b9f
Autor:
Kei Ikeda, Taro Iwamoto, Shunsuke Furuta, Junichi Nakamura, Takeshi Umibe, Masaki Hiraguri, Hiroshi Nakajima, Shin-ichiro Kagami, Yoshihisa Kobayashi, Hirotoshi Kawashima, Ayako Matsuki, Seiji Ohtori, Masashi Fukuta, Daiki Nakagomi, Norihiro Mimura, Takayuki Nakamura, Aiko Saku, Kentaro Takahashi, Yoshie Sanayama, Toyohiko Sugimoto, Koichi Hirose, Hiroaki Takatori, Kenichi Suehiro, Shigekazu Takahashi, Tomohiro Tamachi, Manami Kato, Fumiyoshi Takizawa, Yuya Kawarai, Shigeo Hagiwara
Publikováno v:
RMD Open, Vol 9, Iss 1 (2023)
Objective We aimed to determine the prevalence and risk factors for osteonecrosis of the femoral head (ONFH) in a multicentre cohort of patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV).Methods One hundred and eighty-six A
Externí odkaz:
https://doaj.org/article/0ad3c7cc22724128ab189f6ede6902ef
Autor:
Shunsuke Furuta, Daiki Nakagomi, Yoshihisa Kobayashi, Masaki Hiraguri, Takao Sugiyama, Koichi Amano, Takeshi Umibe, Hajime Kono, Kazuhiro Kurasawa, Yasuhiko Kita, Ryutaro Matsumura, Yuko Kaneko, Keita Ninagawa, Keiju Hiromura, Shin- ichiro Kagami, Yosuke Inaba, Hideki Hanaoka, Kei Ikeda, Hiroshi Nakaji
Publikováno v:
Annals of the Rheumatic Diseases; Jan2024, Vol. 83 Issue 1, p96-102, 7p
Autor:
Norihiro Mimura, Taro Iwamoto, Shunsuke Furuta, Kei Ikeda, Yoshihisa Kobayashi, Takayuki Nakamura, Aiko Saku, Shin-Ichiro Kagami, Ayako Matsuki, Kentaro Takahashi, Takeshi Umibe, Daiki Nakagomi, Yoshie Sanayama, Toyohiko Sugimoto, Masashi Fukuta, Masaki Hiraguri, Hirotoshi Kawashima, Koichi Hirose, Hiroaki Takatori, Kenichi Suehiro, Shigekazu Takahashi, Tomohiro Tamachi, Manami Kato, Fumiyoshi Takizawa, Yuya Kawarai, Shigeo Hagiwara, Junichi Nakamura, Seiji Ohtori, Hiroshi Nakajima
Publikováno v:
RMD Open. 9:e002787
ObjectiveWe aimed to determine the prevalence and risk factors for osteonecrosis of the femoral head (ONFH) in a multicentre cohort of patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV).MethodsOne hundred and eighty-six AAV
Autor:
Hirohumi Ohashi, Norihiro Mimura, Hirotoshi Kawashima, Makio Kawakami, Asuka Shibamiya, Masaki Hiraguri, Atsunari Utsugi, Ryota Hase, Takao Yanagisawa, Kazuma Iida
Publikováno v:
Immunologic Research. 67:99-107
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and immunoglobulin G4-related diseases (IgG4-RD) are regarded as entirely different disease types with different etiological mechanisms. However, we experienced two cases that ha
Autor:
Shunsuke, Furuta, Daiki, Nakagomi, Yoshihisa, Kobayashi, Masaki, Hiraguri, Takao, Sugiyama, Koichi, Amano, Takeshi, Umibe, Hajime, Kono, Kazuhiro, Kurasawa, Yasuhiko, Kita, Ryutaro, Matsumura, Yuko, Kaneko, Keita, Ninagawa, Keiju, Hiromura, Shin-Ichiro, Kagami, Yosuke, Inaba, Hideki, Hanaoka, Kei, Ikeda, Hiroshi, Nakajima, Hiroshi, Otani
Publikováno v:
JAMA
Importance The current standard induction therapy for antineutrophil cytoplasm antibody (ANCA)-associated vasculitis is the combination of high-dose glucocorticoids and cyclophosphamide or rituximab. Although these regimens have high remission rates,
Autor:
Kei, Kobayashi, Daiki, Nakagomi, Shunsuke, Furuta, Yoshiaki, Kobayashi, Shunichiro, Hanai, Mieko, Yamagata, Hirotoshi, Kawashima, Tadamichi, Kasuya, Hiroki, Furuya, Masaki, Hiraguri, Takao, Sugiyama, Hiroshi, Nakajima
Publikováno v:
Clinical and experimental rheumatology. 38(2)
This study researched the efficacy of rituximab (RTX) in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated hypertrophic pachymeningitis (HP).Eight patients were identified by retrospective chart review from local registries at four
Autor:
T. Sugiyama, Daiki Nakagomi, Kei Kobayashi, Hiroshi Nakajima, Tadamichi Kasuya, Kenichiro Kitamura, Shunsuke Furuta, H. Kawashima, Mieko Yamagata, Kei Ikeda, Shunichiro Hanai, Masaki Hiraguri
Publikováno v:
Vasculitis.
Background Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis presents with various symptoms. ANCA-associated hypertrophic pachymeningitis (HP) is a very rare pathology. Objectives This study aimed to investigate the efficacy of rituxi
Autor:
Kei Ikeda, Shunsuke Furuta, Shin-ichiro Kagami, Aiko Saku, Yoshihisa Kobayashi, Takao Sugiyama, Ryutaro Matsumura, Norihiko Watanabe, Masaki Hiraguri, Takeshi Umibe, Hiroshi Nakajima, Kazuhiro Kurasawa, Daiki Nakagomi
Publikováno v:
The Journal of rheumatology. 45(8)
Objective.Patients with eosinophilic granulomatosis with polyangiitis (EGPA) frequently experience relapses, which lead to cumulative organ damage. In this retrospective observational study, we aimed to reveal the risk factors for relapse in EGPA.Met
Autor:
Daisuke Kashiwakuma, Ryutaro Matsumura, Takao Sugiyama, Itsuo Iwamoto, Osamu Ohara, Mieko Yamagata, Makoto Sueishi, Masaki Hiraguri, Kei Ikeda, Takeshi Umibe, Hiroshi Nakajima, Yoshie Sanayama, Shunsuke Furuta, Shin-ichiro Kagami, Nawata Y, Yukari Saito, Ken Nonaka
Publikováno v:
Arthritis & Rheumatology. 66:1421-1431
Objective The aim of this prospective multicenter study was to identify biomarkers that can be used to predict therapeutic responses to tocilizumab in patients with rheumatoid arthritis (RA). Methods We recruited patients with RA who were treated wit